Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: roguedolphin who wrote (77486)	4/10/2008 2:28:22 AM
From: Rolla Coasta	Respond to of 116555

An eye-opener on "Gene Police". Thanks for the link

To: roguedolphin who wrote (77486)	4/18/2008 4:26:49 AM
From: roguedolphin	Respond to of 116555

Buffett, Soros: Betting on Biotech, 'End of the World' Plays Posted Apr 17, 2008 11:46am by Aaron Task \| TechTicker Related: GSK, SNY, MAPP, SVNT, JNJ, GENZ, BRK-B Warren Buffett is the world's richest man and George Soros is hardly a pauper -- having earned nearly $3 billion just last year, according to Alpha magazine. Aside from immense wealth, these two legendary investors have at least one other thing in common: Both are making big bets on healthcare technologies, specifically those involving vaccines, says James Altu cher, managing director of Formula Capital and columnist for The FT and Street.com. Altucher, who literally wrote the book on Buffett's trading, says the "Oracle of Omaha" is actually more focused on demographics than classic valuation metrics, contrary to popular mythology. What Buffett and Soros both see is a world with aging populations in the developing world, greater demand for vaccines in the emerging markets, and the potential for pandemic diseases that threaten all of humanity. Rather than fearing the worst-case scenarios, these billionaires are making big bets on them via investments in names like Glaxosmithkline, Sanofi-Aventis, Johnson & Johnson, MAP Pharmaceuticals, Savient Pharmaceuticals, and others. VIDEO on Biotech Analysis (00:04:23) finance.yahoo.com